The global employer and workplace drug testing market size was estimated at USD 6,105.1 million in 2024 and is projected to reach USD 9,089.9 million by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market focuses on detecting the presence of illicit drugs and controlled substa... Read More »
August 2025The U.S. employer and workplace drug testing market size was estimated at USD 2.57 billion in 2024 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The market is primarily driven by stringent workplace safety regulations, growing awareness ... Read More »
August 2025The global hepatic fibrosis biomarkers market size was estimated at USD 423.51 million in 2024 and is projected to reach USD 2,291.73 million by 2033, growing at a CAGR of 20.01% from 2025 to 2033. The rising prevalence of NASH, a consequence of obesity, sedentary lifestyles, and metabol... Read More »
August 2025The Middle East STD diagnostics market size was estimated at USD 216.56 million in 2024 and is projected to reach USD 390.96 million by 2033, growing at a CAGR of 6.75% from 2025 to 2033. Rising incidence of sexually transmitted infections such as HIV, syphilis, gonorrhea, and chlamydia,... Read More »
August 2025The Middle East human papilloma virus testing market size was estimated at USD 60.02 million in 2024 and is projected to reach USD 203.37 million by 2033, growing at a CAGR of 14.80% from 2025 to 2033. Low HPV vaccine awareness and acceptance in the Middle East, driven by limited inclusi... Read More »
August 2025The global transaminase test market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.81 billion by 2033, growing at a CAGR of 7.54% from 2025 to 2033. This market centers on rapid, accurate diagnostic platforms, such as AST (Aspartate Transaminase) and GOT (... Read More »
August 2025The global HIV Self-testing market size was estimated at USD 211.55 million in 2024 and is expected to reach USD 643.41 million by 2033, growing at a CAGR of 13.55% from 2025 to 2033. This growth is fueled by an increasing emphasis on early HIV detection, rising HIV prevalence, and a glo... Read More »
August 2025The EMEA point-of-care (POC) diagnostics market size was estimated at USD 14.08 billion in 2024 and is projected to reach USD 23.13 billion by 2033, growing at a CAGR of 6.2% from 2025 to 2033. This market emphasizes rapid diagnostic solutions designed for near-patient testing, enabling ... Read More »
August 2025The U.S. human papillomavirus testing market size was estimated at USD 638.37 million in 2024 and is projected to grow at a CAGR of around 13.56% from 2025 to 2033. The market growth is propelled by evolving clinical guidelines, technological innovation, and growing emphasis on preventiv... Read More »
August 2025The human papilloma virus testing market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.67 billion by 2033, growing at a CAGR of 14.14% from 2025 to 2033. The market is fueled by rising HPV-related cancer cases, with human papilloma virus (HPV) causing ove... Read More »
August 2025The Middle East point of care molecular diagnostics market size was valued at USD 273.5 million in 2024 and is projected to reach USD 463.0 million by 2033, growing at a CAGR of 6.13% from 2025 to 2033. The Middle East and Africa (MEA) region encompasses countries with both advanced and ... Read More »
August 2025The global lung cancer diagnostics market size was estimated at USD 12.37 billion in 2024 and is projected to reach USD 23.31 billion by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The market encompasses diagnostic technologies designed to facilitate the early detection and accura... Read More »
August 2025The Middle East in vitro diagnostics market size was estimated at USD 2,093.7 million in 2024 and is projected to reach USD 3,797.5 million by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market is driven by a combination of rising disease prevalence, expanding healthcare infr... Read More »
August 2025The U.S. HSV testing market size was estimated at USD 205.0 million in 2024 and is expected to grow at a CAGR of 5.24% from 2025 to 2033. The market includes a range of diagnostic solutions designed for the accurate and timely detection of herpes simplex virus types 1 and 2. Testing meth... Read More »
August 2025The global molecular diagnostics in pharmacogenomics market size was estimated at USD 699.7 million in 2024 and is projected to reach USD 1, 256.38 million in 2033, growing at a CAGR of 6.84% from 2025 to 2033. This market focuses on rapid and precise genetic testing that enables tailore... Read More »
August 2025The Asia Pacific oncology based molecular diagnostics market size was estimated at USD 822.5 million in 2024 and is projected to reach USD 1,560.75 million by 2033, growing at a CAGR of 6.8% from 2025 to 2033. Rising cancer burden across breast, prostate, and colon, along with the aging ... Read More »
August 2025The U.S. allergy and autoimmune disease diagnostics market size was estimated at USD 4.03 billion in 2024 and is projected to reach USD 8.40 billion by 2033, growing at a CAGR of 8.67% from 2025 to 2033. The market is primarily driven by the rising incidence of allergic and autoimmune di... Read More »
August 2025The U.S. point of care molecular diagnostics market size was estimated at USD 3.23 billion in 2024 and is expected to grow at a CAGR of 5.45% from 2025 to 2033. The market is centered around rapid and decentralized molecular testing that supports quicker clinical decisions at or near the... Read More »
July 2025The global HSV testing market size was estimated at USD 611.97 million in 2024 and is expected to reach USD 1017.75 million by 2033, growing at a CAGR of 5.96% from 2025 to 2033. This market encompasses diagnostic solutions aimed at the timely and reliable detection of herpes simplex vir... Read More »
July 2025The global point of care molecular diagnostics market size was estimated at USD 8.22 billion in 2024 and is projected to reach USD 14.47 billion by 2033, growing at a CAGR of 6.52% from 2025 to 2033. This market focuses on rapid and accurate molecular testing conducted near the patient, ... Read More »
July 2025